Anurag Relan

Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema

Bruce L. Zuraw, Marco Cicardi, Robyn J. Levy et al. · Journal of Allergy and Clinical Immunology · 2010 · 218 citations

Medicine, Pharmacology, Pharmacotherapy +4

A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

V. Koneti Rao, Sharon Webster, Anna Šedivá et al. · Blood · 2022 · 132 citations · Full text

Medicine, Immunology, Pharmacology +13

Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial

Marc A. Riedl, Jonathan A. Bernstein, Henry Li et al. · Annals of Allergy Asthma & Immunology · 2014 · 88 citations

Medicine, Pharmacology, Pharmacotherapy +5

Elevated <scp>D</scp>‐dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk

Avner Reshef, Andrea Zanichelli, Hilary Longhurst et al. · Allergy · 2015 · 72 citations · Full text

Medicine, Hematology, Pharmacology +17

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial

Marc A. Riedl, Vesna Grivcheva‐Panovska, Dumitru Moldovan et al. · The Lancet · 2017 · 64 citations

Medicine, Pharmacology, Pharmacotherapy +6